CD19 and B-cell non-Hodgkin lymphoma: Single-cell RNA sequencing (scRNA-Seq) analysis of CD19 CAR-T cells used in therapy for patients with B cell lymphomas has also revealed that patients with partial or no remission exhibited a higher prevalence of exhaustion-related transcriptional profiles compared to those who achieved complete remission [15].